Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Rheumatology|October 23, 2020
Ten years of the ESSDAI: is it fit for purpose?Liseth de Wolff, Suzanne Arends, Jolien F van Nimwegen, et al.
Arthritis Research & Therapy|October 18, 2023
High BMI is associated with lower TNF-α inhibitor serum trough levels and higher disease activity in patients with axial spondyloarthritisLiseth de Wolff, Suzanne Arends, Elisabeth Brouwer, et al.
Clinical and Experimental Rheumatology|June 15, 2021
Change in disease activity is associated with TNF-α inhibitor serum levels in patients with axial spondyloarthritis in daily clinical practiceLiseth de Wolff, Freke R Wink, Hendrika Bootsma, et al.
Clinical and Experimental Rheumatology|November 19, 2021
Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sjögren's syndromeLiseth de Wolff, Suzanne Arends, Elena Pontarini, et al.
Expert Review of Clinical Immunology|August 8, 2023
Why do drug treatments fail in Sjögren's disease? Considerations for treatment, trial design and interpretation of clinical efficacySuzanne Arends, Gwenny M Verstappen, Liseth de Wolff, et al.
Clinical and Experimental Rheumatology|September 5, 2022
Immunisation with Coronavirus-2 vaccines induces potent antibody responses and does not aggravate the lymphocyte compartment of primary Sjögren's syndrome patientsTobit D Steinmetz, Liseth de Wolff, Janneke H Terpstra, et al.
Clinical and Experimental Rheumatology|October 19, 2021
Clinical determinants of vaginal dryness in patients with primary Sjögren's syndromeClaudette A Farenhorst, Liseth de Wolff, Suzanne Arends, et al.
RMD Open|January 22, 2025
Systemic disease activity measured with ESSDAI varies largely over 5 years in a prospective, longitudinal cohort of patients with Sjögren's diseaseLiseth de Wolff, Gwenny Verstappen, Alja Stel, et al.
Clinical and Experimental Rheumatology|October 28, 2022
Selection of study endpoints and patients for clinical trials in primary Sjögren's syndromeSuzanne Arends, Liseth de Wolff, Liselotte Deroo, et al.
Seminars in Arthritis and Rheumatism|May 28, 2024
Added value of the salivary gland ultrasonography OMERACT score in the ACR/EULAR classification criteria for Sjögren's diseaseDagmar Rebel, Liseth de Wolff, Konstantina Delli, et al.
Pageof 3